Skip to main content
SpringerLink
Log in

Body Cavity Fluids

  • Chapter
  • First Online:
Cytopathology in Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 160))

  • 1739 Accesses

Abstract

Body cavity fluid specimens come from the mesothelium-lined pleural, peritoneal, and pericardial cavities and have much in common with one another. These specimens can pose unique challenges for the cytologist. Although the specimens are relatively simple to obtain, diagnosis is often rendered difficult by the very abundance of material provided for analysis. Isolating and identifying small numbers of diagnostically critical cells in large volumes of fluid can prove difficult.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Manosca F, Schinstine M, Fetsch PA et al (2007) Diagnostic effects of prolonged storage on fresh effusion samples. Diagn Cytopathol 35:6–11

    Article  PubMed  Google Scholar 

  2. Elsheikh TM, Kirkpatrick JL, Wu HH (2006) Comparison of ThinPrep and cytospin preparations in the evaluation of exfoliative cytology specimens. Cancer 108:144–149

    Article  PubMed  Google Scholar 

  3. Gabriel C, Achten R, Drijkoningen M (2004) Use of liquid-based cytology in serous fluids: a comparison with conventional cytopreparatory techniques. Acta Cytol 48:825–835

    Article  PubMed  Google Scholar 

  4. Hoda RS (2007) Non-gynecologic cytology on liquid-based preparations: a morphologic review of facts and artifacts. Diagn Cytopathol 35:621–634

    Article  PubMed  Google Scholar 

  5. Leung CS, Chiu B, Bell V (1997) Comparison of ThinPrep and conventional preparations: nongynecologic cytology evaluation. Diagn Cytopathol 16:368–371

    Article  PubMed  CAS  Google Scholar 

  6. Moriarty AT, Schwartz MR, Ducatman BS et al (2008) A liquid concept–do classic preparations of body cavity fluid perform differently than ThinPrep cases? Observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 132:1716–1718

    PubMed  Google Scholar 

  7. Churg A, Colby TV, Cagle P et al (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24:1183–1200

    Article  PubMed  CAS  Google Scholar 

  8. Wojno KJ, Olson JL, Sherman ME (1994) Cytopathology of pleural effusions after radiotherapy. Acta Cytol 38:1–8

    PubMed  CAS  Google Scholar 

  9. Ozkara SK, Turan G, Basyigit I (2007) Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol 51:773–781

    Article  PubMed  Google Scholar 

  10. Patel NP, Taylor CA, Levine EA, Trupiano JK, Geisinger KR (2007) Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimens: examination of 49 cases at one institution, including post-intraperitoneal hyperthermic chemotherapy findings. Am J Clin Pathol 128:414–422

    Article  PubMed  Google Scholar 

  11. Naylor B (2008) Pleural, peritoneal, and pericardial effusions. In: Bibbo M, Wilbur DC (eds) Comprehensive cytopathology 3rd edn. Saunders, Philadelphia, pp 515–577

    Google Scholar 

  12. Wong JW, Pitlik D, Abdul-Karim FW (1997) Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary. Acta Cytol 41:467–473

    Article  PubMed  CAS  Google Scholar 

  13. Thrall MJ, Giampoli EJ (2009) Routine review of ascites fluid from patients with cirrhosis or hepatocellular carcinoma is a low-yield procedure: an observational study. Cytojournal 6:16

    Article  PubMed  Google Scholar 

  14. Aleman C, Sanchez L, Alegre J et al (2007) Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures. QJM 100:351–359

    Article  PubMed  CAS  Google Scholar 

  15. Ferrer J, Roldan J, Teixidor J, Pallisa E, Gich I, Morell F (2005) Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 127:1017–1022

    Article  PubMed  Google Scholar 

  16. Moriarty AT, Stastny J, Volk EE, Hughes JH, Miller TR, Wilbur DC (2004) Fluids–good and bad actors: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 128:513–518

    PubMed  Google Scholar 

  17. Butnor KJ, Sporn TA, Ordonez NG (2007) Recommendations for the reporting of pleural mesothelioma. Hum Pathol 38:1587–1589

    Article  PubMed  Google Scholar 

  18. Ordonez NG (2005) Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med 129:1407–1414

    PubMed  Google Scholar 

  19. Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347

    Article  PubMed  Google Scholar 

  20. Bangerter M, Hildebrand A, Griesshammer M (2001) Combined cytomorphologic and immunophenotypic analysis in the diagnostic workup of lymphomatous effusions. Acta Cytol 45:307–312

    Article  PubMed  CAS  Google Scholar 

  21. Nador RG, Cesarman E, Chadburn A et al (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 88:645–656

    PubMed  CAS  Google Scholar 

  22. Brimo F, Michel RP, Khetani K, Auger M (2007) Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 111:224–233

    Article  PubMed  Google Scholar 

  23. Abadi MA, Zakowski MF (1998) Cytologic features of sarcomas in fluids. Cancer 84:71–76

    Article  PubMed  CAS  Google Scholar 

  24. Cheng L, Wolf NG, Rose PG, Rodriguez M, Abdul-Karim FW (1998) Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants. Acta Cytol 42:1091–1094

    Article  PubMed  CAS  Google Scholar 

  25. Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL (2005) Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol 18:673–680

    Article  PubMed  Google Scholar 

  26. Kasamatsu T, Onda T, Katsumata N et al (2003) Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 88:245–250

    Article  PubMed  CAS  Google Scholar 

  27. Benevolo M, Mariani L, Vocaturo G, Vasselli S, Natali PG, Mottolese M (2000) Independent prognostic value of peritoneal immunocytodiagnosis in endometrial carcinoma. Am J Surg Pathol 24:241–247

    Article  PubMed  CAS  Google Scholar 

  28. Havrilesky LJ, Cragun JM, Calingaert B et al (2007) The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol 104:401–405

    Article  PubMed  Google Scholar 

  29. Kashimura M, Sugihara K, Toki N et al (1997) The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 67:285–290

    Article  PubMed  CAS  Google Scholar 

  30. Obermair A, Geramou M, Tripcony L, Nicklin JL, Perrin L, Crandon AJ (2001) Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett 164:105–110

    Article  PubMed  CAS  Google Scholar 

  31. Saga Y, Imai M, Jobo T et al (2006) Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol 103:277–280

    Article  PubMed  Google Scholar 

  32. Egarter C, Krestan C, Kurz C (1996) Abdominal dissemination of malignant cells with hysteroscopy. Gynecol Oncol 63:143–144

    Article  PubMed  CAS  Google Scholar 

  33. Biewenga P, de Blok S, Birnie E (2004) Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings? Gynecol Oncol 93:194–198

    Article  PubMed  Google Scholar 

  34. Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ (2001) High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol 80:378–382

    Article  PubMed  CAS  Google Scholar 

  35. Lim S, Kim HS, Lee KB, Yoo CW, Park SY, Seo SS (2008) Does the use of a uterine manipulator with an intrauterine balloon in total laparoscopic hysterectomy facilitate tumor cell spillage into the peritoneal cavity in patients with endometrial cancer? Int J Gynecol Cancer 18:1145–1149

    Article  PubMed  CAS  Google Scholar 

  36. Eltabbakh GH, Mount SL (2006) Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma. Gynecol Oncol 100:361–364

    Article  PubMed  Google Scholar 

  37. Enatsu S, Yoshida J, Yokose T et al (2006) Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients. Ann Thorac Surg 81:298–304

    Article  PubMed  Google Scholar 

  38. Kotoulas C, Lazopoulos G, Karaiskos T et al (2001) Prognostic significance of pleural lavage cytology after resection for non-small cell lung cancer. Eur J Cardiothorac Surg 20:330–334

    Article  PubMed  CAS  Google Scholar 

  39. Lim E, Ali A, Theodorou P, Nicholson AG, Ladas G, Goldstraw P (2004) Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg 127:1113–1118

    Article  PubMed  Google Scholar 

  40. Nakagawa T, Okumura N, Kokado Y, Miyoshi K, Matsuoka T, Kameyama K (2007) Clinical relevance of intraoperative pleural lavage cytology in non-small cell lung cancer. Ann Thorac Surg 83:204–208

    Article  PubMed  Google Scholar 

  41. Okada M, Sakamoto T, Nishio W, Uchino K, Tsuboshima K, Tsubota N (2003) Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections. J Thorac Cardiovasc Surg 126:1911–1915

    Article  PubMed  Google Scholar 

  42. Shintani Y, Ohta M, Iwasaki T et al (2009) Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer. J Thorac Cardiovasc Surg 137:835–839

    Article  PubMed  Google Scholar 

  43. Vicidomini G, Santini M, Fiorello A, Parascandolo V, Calabro B, Pastore V (2005) Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer? Ann Thorac Surg 79:254–257; discussion -7

    Google Scholar 

  44. Bando E, Yonemura Y, Takeshita Y et al (1999) Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 178:256–262

    Article  PubMed  CAS  Google Scholar 

  45. Chuwa EW, Khin LW, Chan WH, Ong HS, Wong WK (2005) Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore. Gastric Cancer 8:228–237

    Article  PubMed  Google Scholar 

  46. Ribeiro U, Jr., Safatle-Ribeiro AV, Zilberstein B et al (2006) Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg 10:170–176, discussion 6–7

    Google Scholar 

  47. de Manzoni G, Verlato G, Di Leo A et al (2006) Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg 30:579–584

    Article  PubMed  Google Scholar 

  48. Nieveen van Dijkum EJ, Sturm PD, de Wit LT, Offerhaus J, Obertop H, Gouma DJ (1998) Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: is it useful? Ann Surg 228:728–733

    Google Scholar 

  49. Cavalli P, Riboli B, Generali D, Passalacqua R, Bosio G (2006) EGFR genotyping in pleural fluid specimens in NSCLC patients. Lung Cancer 54:265–266

    Article  PubMed  Google Scholar 

  50. Kimura H, Fujiwara Y, Sone T et al (2006) EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Br J Cancer 95:1390–1395

    Article  PubMed  CAS  Google Scholar 

  51. Zhang X, Zhao Y, Wang M, Yap WS, Chang AY (2008) Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer. Lung Cancer 60:175–182

    Article  PubMed  Google Scholar 

  52. Davidson B (2004) Malignant effusions: from diagnosis to biology. Diagn Cytopathol 31:246–254

    Article  PubMed  Google Scholar 

  53. Davidson B, Espina V, Steinberg SM et al (2006) Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 12:791–799

    Article  PubMed  CAS  Google Scholar 

  54. Benlloch S, Galbis-Caravajal JM, Martin C et al (2006) Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer 107:1859–1865

    Article  PubMed  CAS  Google Scholar 

  55. Brock MV, Hooker CM, Yung R et al (2005) Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg 80:1241–1247

    Article  PubMed  Google Scholar 

  56. Katayama H, Hiraki A, Aoe K et al (2007) Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Int J Cancer 120:2191–2195

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Methodist Hospital, Houston, TX, USA

    Michael J. Thrall

  2. Weill Cornell College of Medicine, New York, USA

    Michael J. Thrall

Authors
  1. Michael J. Thrall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Thrall .

Editor information

Editors and Affiliations

  1. Feinberg School of Medicine Northwestern University, Chicago, Illinois, USA

    Ritu Nayar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thrall, M.J. (2014). Body Cavity Fluids. In: Nayar, R. (eds) Cytopathology in Oncology. Cancer Treatment and Research, vol 160. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38850-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38850-7_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38849-1

  • Online ISBN: 978-3-642-38850-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation